nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors

Malignant perivascular epithelioid cell tumor (PEComa) is a rare aggressive sarcoma, with no approved treatment. To our knowledge, this phase II, single-arm, registration trial is the first prospective clinical trial in this disease, investigating the safety and efficacy of the mammalian target of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Andrew J., Ravi, Vinod, Riedel, Richard F., Ganjoo, Kristen, Van Tine, Brian A., Chugh, Rashmi, Cranmer, Lee, Gordon, Erlinda M., Hornick, Jason L., Du, Heng, Grigorian, Berta, Schmid, Anita N., Hou, Shihe, Harris, Katherine, Kwiatkowski, David J., Desai, Neil P., Dickson, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
Rapid Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601264/
https://www.ncbi.nlm.nih.gov/pubmed/34637337
http://dx.doi.org/10.1200/JCO.21.01728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601264/
https://www.ncbi.nlm.nih.gov/pubmed/34637337
http://dx.doi.org/10.1200/JCO.21.01728

Ejemplares similares